Medical products company UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 15.1% year on year to $174 million. Its non-GAAP profit of $2.92 per share was 14.2% above analysts’ consensus estimates.
stock
Be The Investor Research
Read Original Source (Finance)
UFP Technologies’s (NASDAQ:UFPT) Q2 CY2026: Strong Sales, Stock Soars
Medical products company UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 15.1% year on year to $174 million. Its non-GAAP profit of $2.92 per share was 14.2% above analysts’ consensus estimates.